U
IGC icon

UBS’s IGC Pharma IGC Stock Holding History

UBS’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1K Buy
+2,112
New +$2.06K ﹤0.01% 10161
2014
Q2 		– Sell
-2,900
Closed -$2K – 10599
2014
Q1 		$2K Buy
2,900
+1,889
+187% +$1.64K ﹤0.01% 10019
2013
Q4 		$1K Buy
1,011
+464
+85% +$430 ﹤0.01% 10188
2013
Q3 		$1K Buy
+547
New +$682 ﹤0.01% 10147

Other funds holding IGC

Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
VIA
Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return

UBS's IGC Position: Q3 2014 in Review

UBS opened a new position in IGC Pharma (IGC) in Q3 2014: 2,112 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #10161 among its holdings. This is a return to the name: UBS previously reported a position in IGC as recently as Q1 2014.

UBS first reported a position in IGC in Q3 2013 and has held it in 4 quarters since. The position peaked at $2K in Q1 2014. 5 funds tracked by Wall St. Rank hold IGC as of Q3 2014.

  • UBS held 2,112 shares of IGC Pharma worth $1K as of Q3 2014.
  • IGC Pharma was a new UBS position in Q3 2014.
  • IGC Pharma made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10161 holding.
  • UBS first reported a position in IGC Pharma in Q3 2013 and has held it in 4 quarters since.
  • UBS's IGC Pharma position peaked at $2K in Q1 2014.
  • 5 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.